全球医药物流市场规模、份额、趋势及成长分析报告（2026-2034）

预计医药物流市场将从 2025 年的 1,089.5 亿美元成长到 2034 年的 1,907.4 亿美元，2026 年至 2034 年的复合年增长率为 6.42%。

由于对高效能药品运输和储存的需求不断增长，全球医药物流市场正显着扩张。医药物流涉及药品、疫苗和医疗用品的配送管理，同时严格控製品管和温度。全球医药贸易的扩张进一步凸显了可靠物流系统的重要性。

市场成长主要受药品生产规模扩大和对温控供应链需求增加的驱动。许多药品，特别是生物製药和疫苗，需要专门的低温运输物流来维持其疗效。物流供应商正在投资先进的追踪系统和温度监控技术，以确保敏感医疗产品的安全运输。

随着全球医疗保健需求持续成长，医药物流市场前景依然强劲。先进低温运输技术和数位化供应链管理系统的发展可望提升效率和透明度。新兴市场药品出口的成长和医疗基础设施的扩建预计将为物流供应商创造新的商机。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球医药物流市场：依供应类型划分

• 市场分析、洞察与预测
• 低温运输
• 非低温运输

第五章：全球医药物流市场：依服务类型划分

• 市场分析、洞察与预测
• 运输
• 贮存
• 监视

第六章 全球医药物流市场：依运输方式划分

• 市场分析、洞察与预测
• 航空
• 海
• 路
• 铁路

第七章 全球医药物流市场：依应用领域划分

• 市场分析、洞察与预测
• 生物製药
• 化学製药
• 专业製药

第八章 全球医药物流市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • CH Robinson
  • CEVA Logistics
  • DB Schenker
  • DHL Group
  • DSV A/S
  • FedEx Corporation
  • Kuehne+Nagel International AG
  • AP Moller "" Maersk
  • Nippon Express Holdings Inc
  • United Parcel Service（UPS）

The Pharmaceutical Logistics Market size is expected to reach USD 190.74 Billion in 2034 from USD 108.95 Billion (2025) growing at a CAGR of 6.42% during 2026-2034.

The global pharmaceutical logistics market has grown significantly due to increasing demand for efficient transportation and storage of pharmaceutical products. Pharmaceutical logistics involves managing the distribution of medicines, vaccines, and medical supplies while maintaining strict quality and temperature control. The rise in global pharmaceutical trade has strengthened the importance of reliable logistics systems.

Market growth is driven by expanding pharmaceutical production and the increasing need for temperature-controlled supply chains. Many medicines, especially biologics and vaccines, require specialized cold chain logistics to maintain product effectiveness. Logistics providers are investing in advanced tracking systems and temperature monitoring technologies to ensure safe delivery of sensitive medical products.

The future outlook for the pharmaceutical logistics market remains strong as global healthcare demand continues to rise. The development of advanced cold chain technologies and digital supply chain management systems may improve efficiency and transparency. Growing pharmaceutical exports and expanding healthcare infrastructure in emerging markets are expected to create new opportunities for logistics providers.

MARKET SEGMENTATION

By Offering

• Cold Chain
• Non-Cold Chain

By Service

• Transportation
• Storage
• Monitoring

By Mode of Transportation

• Air
• Sea
• Road
• Rail

By Application

• Biopharma
• Chemical Pharma
• Specialty Pharma

COMPANIES PROFILED

• CH Robinson, CEVA Logistics, DB Schenker, DHL Group, DSV AS, FedEx Corporation, Kuehne Nagel International AG, AP Moller Maersk, Nippon Express Holdings Inc, United Parcel Service UPS
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PHARMACEUTICAL LOGISTICS MARKET: BY OFFERING 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Offering
• 4.2. Cold Chain Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Non-Cold Chain Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PHARMACEUTICAL LOGISTICS MARKET: BY SERVICE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Service
• 5.2. Transportation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Storage Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PHARMACEUTICAL LOGISTICS MARKET: BY MODE OF TRANSPORTATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Mode Of Transportation
• 6.2. Air Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Sea Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Road Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Rail Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PHARMACEUTICAL LOGISTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Biopharma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Chemical Pharma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Specialty Pharma Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PHARMACEUTICAL LOGISTICS MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Offering
  • 8.2.2 By Service
  • 8.2.3 By Mode Of Transportation
  • 8.2.4 By Application
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Offering
  • 8.3.2 By Service
  • 8.3.3 By Mode Of Transportation
  • 8.3.4 By Application
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Offering
  • 8.4.2 By Service
  • 8.4.3 By Mode Of Transportation
  • 8.4.4 By Application
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Offering
  • 8.5.2 By Service
  • 8.5.3 By Mode Of Transportation
  • 8.5.4 By Application
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Offering
  • 8.6.2 By Service
  • 8.6.3 By Mode Of Transportation
  • 8.6.4 By Application
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PHARMACEUTICAL LOGISTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 C.H. Robinson
  • 10.2.2 CEVA Logistics
  • 10.2.3 DB Schenker
  • 10.2.4 DHL Group
  • 10.2.5 DSV A/S
  • 10.2.6 FedEx Corporation
  • 10.2.7 Kuehne + Nagel International AG
  • 10.2.8 A.P. Moller "" Maersk
  • 10.2.9 Nippon Express Holdings Inc
  • 10.2.10 United Parcel Service (UPS)